SCHEMBL23309488

SCHEMBL23309488

O=C(Nc1nccs1)c1cc(F)nc(F)c1F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.52
▸ NPC1 O15118 7/20 0.51
▸ RAB9A P51151 7/20 0.51
▸ ALDH1A1 P00352 4/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ GAA P10253 1/20 0.51
▸ KCNMA1 Q12791 1/20 0.51
▸ MAPT P10636 2/20 0.50
▸ POLB P06746 1/20 0.50
▸ ESR2 Q92731 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ GCK P35557 1/20 0.50
▸ MEN1 O00255 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ HPGD P15428 2/20 0.48
▸ LMNA P02545 2/20 0.48
▸ PKM P14618 1/20 0.48
▸ METAP2 P50579 1/20 0.48
▸ METAP1 P53582 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309505 0.78 ALDH1A1 (0.43) NPC1RAB9AALDH1A1MAPTPOLB
SCHEMBL23309574 0.77 ALDH1A1 (0.52) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL23309730 0.75 KMT2A (0.47) NPC1RAB9AALDH1A1SMN1; SMN2GAA
SCHEMBL4965216 0.74 CYP1A2 (0.63) CYP1A2NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL23309555 0.74 HTT (0.55) NPC1RAB9AKCNMA1L3MBTL1
SCHEMBL419202 0.74 CYP1A2 (0.71) CYP1A2NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL23309532 0.73 RAB9A (0.51) NPC1RAB9AALDH1A1SMN1; SMN2GAA
SCHEMBL23309507 0.73 NPC1 (0.57) NPC1RAB9AALDH1A1SMN1; SMN2GAA
SCHEMBL8797043 0.73 RAB9A (0.62) NPC1RAB9ASMN1; SMN2MAPTPOLB
SCHEMBL4293361 0.72 NPC1 (0.62) CYP1A2NPC1RAB9AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL CYP1A2 1133/4885NPC1 412/4885RAB9A 286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback